|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Tachycardia - induced cardiomyopathy in childhood 显示文摘 | Boveda S Albenque JP Marijon E | 2010 | Arch Cardiovasc Dis2010，103，5： | 1 |
| 2 | Incidence of sports-related sudden death in France by specific sports and sex显示文摘 | Marijon E Bougouin W Perier M | 2013 | Jama-the Journal of the American Medical Association2013，310，6： | 1 |
| 3 | Tachycardia-induced cardiomyopathy in childhood显示文摘 | Boveda S Albenque JP Marijon E | | 0，，05： | 1 |
| 4 | Pathophysiology of atrial- fibrillition:insights into the renin-angiotensin sistem显示文摘 | Le-Heuzey JY Marijon E Chach K | 2008 | Arch Car- diovasc Dis2008，101，1112： | 1 |
| 5 | Real‐Time Contact Force Sensing for Pulmonary Vein Isolation in the Setting of Paroxysmal Atrial Fibrillation: Procedural and 1‐Year Results显示文摘 | ELOI MARIJON SAMIA FAZAA KUMAR NARAYANAN BENOIT GUY‐MOYAT ABDESLAM BOUZEMAN RUI PROVIDENCIA FREDERIC TREGUER NICOLAS COMBES AGUSTIN BORTONE SERGE BOVEDA STEPHANE COMBES JEAN‐PAUL ALBENQUE | 2014 | J Cardiovasc Electrophysiol2014，，2： | 1 |
| 6 | Incidence and prognostic significance of sustained ventrieular tachycardias in heart failure patients implanted with biventricular pacemakers without a back-up defibrillator:results from the prospective,multicentre,Mona Lisa cohort study显示文摘 | Boveda S Marijon E Jacob S | 2009 | Eur Heart J2009，30，10： | 1 |
| 7 | Prevalence of rheumatic heart disease detected by echocardiographic screening 显示文摘 | Marijon E Phalla OU David S | 2007 | N Engl J Med2007，357，5： | 1 |
| 8 | Rheumatic heart disease 显示文摘 | Marijon E Mirabel M Celermajer DS | 2012 | Lancet2012，379，9819： | 1 |
| 9 | Meta-Analysis of the Influence of Chronic Kidney Disease on the Risk of Thromboembolism Among Patients With Nonvalvular Atrial Fibrillation显示文摘 | Providencia R Marijon E Boveda S | 2014 | Am J Cardiol2014，114，4： | 1 |
| 10 | Prevalence of rheumatic heart disease detected by echocardiographic screening 显示文摘 | Marijon E Ou P Celermajer DS | 2007 | N Engl J Med2007，357，5： | 1 |
| 11 | Pathophysiology of atri-al fibrillation:insights into the renin-angiotensin system显示文摘 | Le Heuzey JY Marijon E Chachoua K | 2008 | Arch Cardiovasc Dis2008，101，1112： | 1 |
| 12 | FOLFIRI3-aflibercept in previously treated patients with metastatic colorectal cancer显示文摘AIM To evaluate the efficacy and safety of the modified FOLFIRI3-aflibercept as second-line therapy in patients with metastatic colorectal cancer.METHODS This is a retrospective multicenter cohort, evaluating the efficacy and safety of the association of aflibercept with FOLFIRI3(day 1: aflibercept 4 mg/kg, folinic acid 400 mg/m^2, irinotecan 90 mg/m^2, 5-fluorouracil infusion 2400 mg/m^2 per 46 h; day 3: irinotecan 90 mg/m^2) in patients with previously treated metastatic colorectal cancer. The primary endpoint was overall response rate(ORR). Secondary endpoints were disease control rate(DCR), progression-free survival(PFS), overall survival(OS), and safety.RESULTS Among 74 patients treated in four French centers, nine were excluded due to prior use of aflibercept(n = 3), more than one prior treatment line in irinotecanna?ve patients(n = 3), and inadequate liver function(n = 3). In the 'irinotecan-na?ve' patients(n = 30), ORR was 43.3% and DCR was 76.7%. Median PFS and OS were 11.3 mo(95%CI: 6.1-29.0) and 17.0 mo(95%CI: 13.0-17.3), respectively. The most common(> 5%) grade 3-4 adverse events were diarrhea(37.9%), neutropenia(14.3%), stomatitis and anemia(10.4%), and hypertension(6.7%). In the 'pre-exposed irinotecan' patients(n = 35), 20(57.1%) received ≥ 2 prior lines of treatment. ORR was 34.3% and DCR was 60.0%. Median PFS and OS were 5.7 mo(95%CI: 3.9-10.4) and 14.3 mo(95%CI: 12.8-19.5), respectively.CONCLUSION Minimally modified FOLFIRI has improvement dramatically the FOLFIRI3-aflibercept efficacy, whatever prior use of irinotecan. A prospective randomized trial is warranted to compare FOLFIRI-aflibercept to FOLFIRI3-aflibercept. | CANDice Carola Fran?ois Ghiringhelli Stefano Kim Thierry ANDré Juliette Barlet Le?la Bengrine-Lefevre Hélène Marijon Marie-Line Garcia-Larnicol Christophe Borg Linda Dainese Nils Steuer Hubert Richa Magdalena Benetkiewicz Annette K Larsen Aimery de Gramont Benoist Chibaudel | 2018 | World Journal of Clinical Oncology2018，9，5： | 1 |
| 13 | Impact of early statin therapy on development of atrial fibrillation at the acute stage of myocardial infarction:data from the FAST-MI register显示文摘 | Danchin N Fauchier L Marijon E | 2010 | Heart2010，96，22： | 1 |
| 14 | Is isolated congenital heart block with maternal antibodies a distinct and more severe form of the diseasein childhood显示文摘 | Villain E Marijon E Gcorgin S | 2005 | Heart Rhythm2005，2，5： | 1 |
| 15 | Cardiovascu- lar Disease in the Developing WorldPrevalences, Patterns, and the Potential of Early Disease Detection 显示文摘 | Celermajer D S Chow C K Marijon E | 2012 | Journal of the American College of Cardiology2012，60，14： | 1 |
| 16 | Real-time contact force sensing for pulmonary vein isolation in the setting of paroxysmal atrial fibrillation:procedural and 1-year results显示文摘 | Marijon E Fazaa S Narayanan K | 2014 | J Cardiovasc Electrophysiol2014，25，2： | 1 |
| 17 | Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study显示文摘 | Marijon E Le Heuzey JY Connolly S | 2013 | Circulation2013，128，： | 1 |
| 18 | Complete atrioventricular block and asystole in a patient with an inferior acute myocardial infarction ; what is the mechanismfi 显示文摘 | Borone A Albenque JP Marijon E | 2008 | Heart Rhythm2008，5，： | 1 |
| 19 | Incidence and prognostic significance of sustained ventricular taehycardias in heart failure patients implanted with biventricular pacemakers without a back-up defibrillator: results from the prospective, multicentre, Mona Lisa coholt study显示文摘 | Boveda S Marijon E Jacob S | 2009 | Eur Heart J2009，30，： | 1 |
| 20 | Real-time contact force sensing for pulmonary vein isolation in the setting of paroxysmal at- rial fibrillation : procedural and 1-year results 显示文摘 | Marijon E Fazaa S Narayanan K | 2014 | J Cardiovasc Electrophysio12014，25，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员